During the intermediate phase - between 6 and 12 h - neurological damage develops accounting for 17% mortality and, to a larger extent, for morbidity at discharge.
La fase intermedia, entre6a12 h,protagoniza el daño neurológico, causante del 17% de mortalidad y en mayor medida la morbilidad al alta hospitalaria.